Latest Articles
- Interpreting the COMET trial
Although survival was better with carvedilol than with immediate-release metoprolol tartrate, we must increase the use of any approved beta-blocker in heart failure.
Endovascular therapy or conventional vascular surgery? A complex choiceAortic aneurysms, carotid stenosis, peripheral vascular disease, and stenosis of visceral vessels can now be treated percutaneously, but less invasive isn’t always better.
- Who should be taking aspirin to prevent coronary events?
How to use the estimated coronary risk in deciding whether to prescribe long-term aspirin therapy, with an algorithm and three brief examples.
- Age-related macular degeneration: Evaluation and treatment
Any patient age 50 or older with vision loss or distorted vision deserves an immediate referral to an ophthalmologist. Hypertension control and smoking cessation are important.
- Up pops the devil
The COMET trial is important for the treatment of heart failure, but the devil is in the details.
- Skin rash in a transplant patient receiving multiple drugs
He is on heparin, trimethoprim-sulfamethoxazole, cyclosporine, and prednisone. Which one is the culprit, and what should be done?